6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair
NCT06998680 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152
Last updated 2025-09-19
Summary
This will be a 6-month randomized, double-blind, placebo-controlled trial. A total of 152 participants with hair loss, including some with gray hair, will be enrolled and randomly assigned to four groups. Each group will receive a combination of oral capsules and hair tonic, to be used as directed for 24 weeks. Participants will attend three in-person visits, during which assessments-including hair-related tests and photographs-will be conducted to evaluate hair count and density. Additionally, 10 participants with gray hair from each group will undergo extra assessments focused on changes in hair color. All relevant clinical data will be systematically collected and recorded for statistical analysis.
Conditions
- Alopecia
- Canities
Interventions
- OTHER
-
VitaGreen Capsule A+VitaGreen Tonic
VitaGreen Capsule A+VitaGreen Tonic,use 24 weeks
- OTHER
-
VitaGreen Capsule B+VitaGreen Tonic
VitaGreen Capsule B+VitaGreen Tonic,use 24 weeks
- OTHER
-
Capsule Placebo+VitaGreen Tonic
Capsule Placebo+VitaGreen Tonic,use 24 weeks
- OTHER
-
Capsule Placebo+Tonic Placebo
Capsule Placebo+Tonic Placebo,use 24 weeks
Sponsors & Collaborators
-
Vita Green Pharmaceutical (H.K.) Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-07-30
- Primary Completion
- 2026-06-30
- Completion
- 2026-10-30
Countries
- China
Study Locations
More Related Trials
-
Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir
NCT07271212 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
NCT05296863 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of the Composition From Fish on Promoting Hair Growth
NCT05450861 ·Status: COMPLETED ·Phase: NA
-
Scalp Care Efficacy Evaluation for Premium Scalp Revitalizing Essence
NCT06985121 ·Status: COMPLETED ·Phase: NA
-
A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia
NCT05827991 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients
NCT06562894 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Phase III Study of KX-826 With Adult Male Patients With AGA
NCT06126965 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium
NCT06545552 ·Status: COMPLETED ·Phase: NA
-
To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia
NCT06409650 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
NCT02067260 ·Status: COMPLETED ·Phase: NA
-
Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair
NCT05339958 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men
NCT05989165 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of a Nutraceutical in Aging Males With Thinning Hair
NCT06854575 ·Status: TERMINATED ·Phase: NA
-
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
NCT07076706 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
NCT03532958 ·Status: WITHDRAWN ·Phase: PHASE2
-
Hydraderm for Androgenic Alopecia
NCT05426629 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
NCT02154503 ·Status: UNKNOWN ·Phase: PHASE1
-
Hair Regeneration in Androgenetic Alopecia
NCT06066827 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
NCT07038941 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
NCT07012486 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Clinical Study to Assess Safety, Efficacy and In-use Tolerability of Different Dosages of Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III).
NCT06551818 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%
NCT03753113 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata
NCT05470413 ·Status: UNKNOWN ·Phase: PHASE3
-
Study Evaluating the Effects of Dietary Supplement on Hair Thickness and Hair Strength in Individuals With Self-Perceived Thinning Hair
NCT06605768 ·Status: COMPLETED ·Phase: NA
-
Combined Microneedling and Topical Pentoxifylline Vesrus Intalesional Pentoxifylline in Treatment of Alopecia Areata: Intra-indiviual Comparative Study
NCT05502952 ·Status: UNKNOWN ·Phase: NA